ABSTRACT
The etiology of tinea capitis changes over time, mainly due to trends in migration. We report 19 cases of tinea capitis caused by Microsporum audouinii, an uncommon agent in South America, all of them confirmed by molecular methods. All patients were male. The average age was 6.1 years. Fifteen patients were residents of Rio de Janeiro city and four were from neighboring cities. Among the patients submitted to follow-up, griseofulvin was prescribed for eight of them. Due to medication shortages, terbinafine was prescribed for five patients, needing to be switched in three cases, with a bigger total average time until clinical improvement. The study reaffirms the emergence of a new etiological agent in Rio de Janeiro, Brazil.
The etiology of tinea capitis changes over time, mainly due to migratory flows. We report 19 cases of tinea capitis caused by Microsporum audouinii, an uncommon agent in South America, all of them confirmed by molecular methods. The study reaffirms the emergence of a new etiological agent in Rio de Janeiro, Brazil.
Subject(s)
Antifungal Agents , Griseofulvin , Microsporum , Terbinafine , Tinea Capitis , Humans , Tinea Capitis/microbiology , Tinea Capitis/drug therapy , Tinea Capitis/epidemiology , Brazil/epidemiology , Microsporum/isolation & purification , Male , Antifungal Agents/therapeutic use , Child , Child, Preschool , Griseofulvin/therapeutic use , Terbinafine/therapeutic use , Adolescent , InfantABSTRACT
A 6-year-old Hispanic patient presented with a 1-month history of pruritic patches on her scalp, characterized by hair loss, black dots, and dandruff-like scales. The patient was seen by her primary care physician, who prescribed ketoconazole 2% shampoo. This provided little relief for her symptoms, which prompted her admission to nearby hospital, where fluconazole was administered intravenously and mometasone lotion applied. The patient was discharged and instructed to use the ketoconazole shampoo and mometasone lotion. The previously prescribed medications failed to improve her now enlarged, inflamed, scaly, pustule-speckled lesions. Given her condition, she was admitted to the University Pediatric Hospital in San Juan, where the Dermatology Department was consulted. Cultures were taken from the lesions, revealing the presence of Trichophyton tonsurans, which led to the diagnosis of tinea capitis (ringworm of the scalp) with kerion formation. In addition, multiple nits and adult lice characteristic of Pediculus humanus capitis were observed. A 6-week course of griseofulvin, a 1-week course of permethrin solution, and a 5-day course of oral prednisolone were started, effectively cleared the patient's inflammation and fungal infection. This case highlights how there exist areas of improvement in terms of interprofessional communication between physicians, as well a need to increase awareness of the proper treatment for this common pediatric skin condition. We postulate that in doing so, similar cases could be spared the unfortunate results of untreated tinea capitis, that is, kerion formation and the possible scarring this lesion can produce.
Subject(s)
Antifungal Agents , Tinea Capitis , Humans , Tinea Capitis/drug therapy , Tinea Capitis/microbiology , Female , Child , Antifungal Agents/administration & dosage , Time Factors , Griseofulvin/administration & dosage , Treatment DelaySubject(s)
Tinea Capitis , Child , Humans , Tinea Capitis/drug therapy , Trichophyton , Antifungal Agents/therapeutic useABSTRACT
THE COMPARISON Areas of alopecia with erythema and scale in a young Black boy with tinea capitis. He also had an enlarged posterior cervical lymph node (arrow) from this fungal infection. White patches of scale from tinea capitis in a young Black boy with no obvious hair loss; however, a potassium hydroxide preparation from the scale was positive for fungus. A subtle area of tinea capitis on the scalp of a Latina girl showed comma hairs.
Subject(s)
Lymphadenopathy , Tinea Capitis , Male , Female , Humans , Dermoscopy , Tinea Capitis/diagnosis , Tinea Capitis/drug therapy , Hair , Scalp , AlopeciaABSTRACT
Dermatophytoses are fungal infections affecting the skin and cutaneous annexes. This clinical case report describes a 7-year-old girl with Kerion celsi, a severe manifestation of Tinea capitis. The patient presented with painful edematous crusty scalp lesions and alopecia, which required surgical debridement and long-term antifungal treatment. Culture of samples collected from scalp and arm skin lesions (patient and patient's mother respectively) were positive for Trichophyton mentagrophytes. The family owned a pet guinea pig. This particular dermatophytosis is easily transmitted from guinea pigs to humans, with some studies showing up to 34.9% prevalence of Trichophyton mentagrophytes infection in these animals.
Subject(s)
Tinea Capitis , Tinea , Alopecia/diagnostic imaging , Alopecia/drug therapy , Animals , Antifungal Agents , Guinea Pigs , Humans , Skin/diagnostic imaging , Skin/pathology , Tinea/drug therapy , Tinea/microbiology , Tinea/pathology , Tinea Capitis/diagnostic imaging , Tinea Capitis/drug therapy , Tinea Capitis/epidemiologyABSTRACT
We examine management practices of tinea capitis at 2 US academic centers. The majority of providers treated tinea capitis with the oral antifungal agent griseofulvin and did not obtain a fungal culture. We recommend newer antifungal treatments such as terbinafine and fluconazole and obtaining a fungal culture for effective treatment.
Subject(s)
Antifungal Agents/therapeutic use , Practice Patterns, Physicians'/statistics & numerical data , Tinea Capitis/diagnosis , Tinea Capitis/drug therapy , Academic Medical Centers , Adolescent , Child , Child, Preschool , Cross-Sectional Studies , Emergency Service, Hospital , Female , Fluconazole/therapeutic use , Griseofulvin/therapeutic use , Humans , Male , Pediatrics , Retrospective Studies , Terbinafine/therapeutic use , United StatesABSTRACT
A descriptive observational and cross-sectional study was carried out. The clinical characteristics, etiologic agents, treatments and outcome of 33 cases of tinea capitis in the Mycology Unit at Francisco J. Muñiz Hospital of Buenos Aires City between January 2015 and December 2019 were analyzed. The median age of the patients was 7 years, 21 of whom were male, 3 were HIV-positive and 22 had pets. The isolated etiologic agents were the following: Microsporum canis in 22 cases, Trichophyton tonsurans in 8, Nannizzia gypsea in 2 and Trichophyton mentagrophytes in one patient. Suppurative tinea capitis (krion Celsi) was detected in 10 cases and the same number of patients presented other skin locations of their dermatophytosis in addition to those in the scalp. Twenty-one cases were orally treated with griseofulvin and 12 with terbinafine. Those patients with suppurative tinea capitis received drops of betamethasone by mouth besides the antifungal drugs. All patients had good clinical and mycological response to the treatments, all lesions disappeared, and mycological studies turned negative by the end of the treatments. We conclude that both drugs were effective for the treatment of tinea capitis; however, lesions in those cases receiving terbinafine involuted more slowly.
Subject(s)
Naphthalenes , Tinea Capitis , Antifungal Agents/therapeutic use , Child , Cross-Sectional Studies , Griseofulvin/therapeutic use , Humans , Male , Terbinafine/therapeutic use , Tinea Capitis/diagnosis , Tinea Capitis/drug therapy , Tinea Capitis/epidemiology , TrichophytonABSTRACT
The patient had a history of treatment for head lice, but a dermatoscopic exam revealed that lice weren't to blame for his itchy scalp.
Subject(s)
Antifungal Agents/therapeutic use , Fluconazole/therapeutic use , Scalp Dermatoses/diagnosis , Scalp Dermatoses/drug therapy , Scalp Dermatoses/microbiology , Tinea Capitis/diagnosis , Tinea Capitis/drug therapy , Animals , Child , Humans , Male , Panama , Treatment OutcomeABSTRACT
La tiña capitis (TC) es una infección por dermatofitos con una alta prevalencia en la población pediátrica. Su epidemiología ha cambiado en las últimas décadas debido a la creciente migración poblacional alrededor del mundo. Se han identificado factores de riesgo ambientales y propios del huésped, relacionados al desarrollo de esta infección. Las manifestaciones clínicas son variables y dependen del agente causal. La dermatoscopia y la luz de Wood son herramientas útiles para la aproximación diagnóstica, sin embargo, la confirmación de la infección se basa en las pruebas micológicas. El aislamiento del agente causal permite orientar el tratamiento antifúngico adecuado, siendo estos eficaces y seguros en población pediátrica. El tratamiento se centra en la terapia antimicótica sistémica en combinación con medidas locales. El objetivo del manuscrito es hacer una revisión actualizada sobre el enfoque clínico y terapéutico de la TC en población pediátrica.
Tinea capitis (TC) is a dermatophyte infection with a high prevalence in the pediatric population. Its epidemiology has changed in recent decades due to increasing population migration worldwide. Environmental and host-specific risk factors have been identified which are with the development of this infection. The clinical manifestations are variable and depend on the causal agent. Dermatosco- py and Wood's lamp are useful tools for the diagnostic approach; however, the confirmation of in fection is based on mycological tests. The identification of the causal agent allows guiding the appro priate antifungal treatment, which is specific and safe in the pediatric population. Treatment focuses on systemic antifungal therapy combined with local measures. The objective of this paper is to carry out an updated review of the clinical and therapeutic approach to TC in the pediatric population.
Subject(s)
Humans , Child, Preschool , Child , Tinea Capitis/diagnosis , Tinea Capitis/microbiology , Tinea Capitis/drug therapy , Tinea Capitis/epidemiology , Global Health , Prevalence , Dermoscopy , Diagnosis, Differential , Antifungal Agents/therapeutic useABSTRACT
Tinea capitis (TC) is a dermatophyte infection with a high prevalence in the pediatric population. Its epidemiology has changed in recent decades due to increasing population migration worldwide. Environmental and host-specific risk factors have been identified which are with the development of this infection. The clinical manifestations are variable and depend on the causal agent. Dermatosco- py and Wood's lamp are useful tools for the diagnostic approach; however, the confirmation of in fection is based on mycological tests. The identification of the causal agent allows guiding the appro priate antifungal treatment, which is specific and safe in the pediatric population. Treatment focuses on systemic antifungal therapy combined with local measures. The objective of this paper is to carry out an updated review of the clinical and therapeutic approach to TC in the pediatric population.
Subject(s)
Tinea Capitis , Antifungal Agents/therapeutic use , Child , Child, Preschool , Dermoscopy , Diagnosis, Differential , Global Health , Humans , Prevalence , Tinea Capitis/diagnosis , Tinea Capitis/drug therapy , Tinea Capitis/epidemiology , Tinea Capitis/microbiologyABSTRACT
Tinea capitis caused by Microsporum audouinii is reported herein from two Brazilian schoolchildren, which are brothers. Arthroconidia were evidenced on direct examination of scalp hair, and a fungus of the genus Microsporum was isolated from cultures of each patient. The isolated fungi were classified as M. audouinii by visualization of species-specific structures, including: pectinate hyphae, chlamydospores, and fusiform macroconidia, sterile growth with characteristic brown pigment in rice grains, and through DNA sequencing of the internal transcriber spacer region. Patients were refractory to ketoconazole, but the two cases had a satisfactory response to oral terbinafine. All M. audouinii infections described in this century were reviewed, and to our knowledge, this is the first literature description of this species from South America. Misidentification of M. audouinii with Microsporum canis can occur in this area, leading to erroneous data about the occurrence of this species.
Subject(s)
Antifungal Agents/therapeutic use , Microsporum/isolation & purification , Naphthalenes/therapeutic use , Tinea Capitis/drug therapy , Aged , Brazil , Child , Child, Preschool , DNA, Intergenic/genetics , Drug Resistance, Fungal , Female , Hair/microbiology , Humans , Ketoconazole/therapeutic use , Male , Microbial Sensitivity Tests , Microsporum/drug effects , Scalp/microbiology , Skin/microbiology , Terbinafine , Tinea Capitis/microbiologyABSTRACT
Destacado dermatólogo, el doctor Julio V. Uriburu propició el estudio de las afecciones micóticas en nuestro medio. Realizamos una breve actualización del diagnóstico y tratamiento de tiñas de cuero cabelludo.
Dr. Julio V. Uriburu was a very important specialist in skin disorders. He worked in the investigation of micotics infections of hair and scalp disorders. We did a review of diagnostic and treatment of tinea capitis.
Subject(s)
Mycology/history , Tinea Capitis/diagnosis , Tinea Capitis/drug therapy , Antifungal Agents/therapeutic use , Dermatology/history , Dermatologists/history , Tinea Capitis/therapy , Retrospective Studies , Observational StudySubject(s)
Antifungal Agents/administration & dosage , Fluconazole/administration & dosage , Griseofulvin/administration & dosage , Tinea Capitis/drug therapy , Administration, Oral , Antifungal Agents/therapeutic use , Drug Administration Schedule , Female , Fluconazole/therapeutic use , Griseofulvin/therapeutic use , Humans , Infant , Infant, Newborn , MaleABSTRACT
Abstract Tinea capitis is generally considered as the most frequent fungal infection in childhood, as it accounts for approximately 92% of all mycosis in children. The epidemiology of this disease varies widely ranging from antropophillic, zoophilic, and geophillic dermatophytes, as the main causative agent in different geographic areas, depending on several additional factors. Nowadays, the etiology is considered to vary with age, as well with gender, and general health condition. The former reported extraordinary Tinea capitis case reports have been replaced by original articles and researches dealing with progressively changing patterns in etiology and clinical manifestation of the disease. This fact is indicative that under the umbrella of the well-known disease there are facts still hidden for future revelations. Herein, we present two rare cases of Tinea capitis in children, which totally differ from the recently established pattern, in their clinical presentation, as well as in the etiological aspect, as we discuss this potential new etiological pattern of the disease, focusing on our retrospective and clinical observation. Collected data suggest that pathogenic molds should be considered as a potential source of infection in some geographic regions, which require total rationalization of the former therapeutic conception, regarding the molds’ higher antimitotic resistance compared to dermatophytes. Molds-induced Tinea capitis should be also considered in clinically resistant and atypical cases, with further investigations of the antifungal susceptibility of the newest pathogens in the frame of the old disease. Further investigations are still needed to confirm or reject this proposal.
Subject(s)
Humans , Male , Female , Child, Preschool , Child , Aspergillosis/drug therapy , Aspergillus niger/isolation & purification , Tinea Capitis/microbiology , Scalp/microbiology , Tinea Capitis/drug therapy , Retrospective Studies , Antifungal Agents/therapeutic useABSTRACT
Tinea capitis is generally considered as the most frequent fungal infection in childhood, as it accounts for approximately 92% of all mycosis in children. The epidemiology of this disease varies widely ranging from antropophillic, zoophilic, and geophillic dermatophytes, as the main causative agent in different geographic areas, depending on several additional factors. Nowadays, the etiology is considered to vary with age, as well with gender, and general health condition. The former reported extraordinary Tinea capitis case reports have been replaced by original articles and researches dealing with progressively changing patterns in etiology and clinical manifestation of the disease. This fact is indicative that under the umbrella of the well-known disease there are facts still hidden for future revelations. Herein, we present two rare cases of Tinea capitis in children, which totally differ from the recently established pattern, in their clinical presentation, as well as in the etiological aspect, as we discuss this potential new etiological pattern of the disease, focusing on our retrospective and clinical observation. Collected data suggest that pathogenic molds should be considered as a potential source of infection in some geographic regions, which require total rationalization of the former therapeutic conception, regarding the molds' higher antimitotic resistance compared to dermatophytes. Molds-induced Tinea capitis should be also considered in clinically resistant and atypical cases, with further investigations of the antifungal susceptibility of the newest pathogens in the frame of the old disease. Further investigations are still needed to confirm or reject this proposal.